plasmodium-vivax

Documents about plasmodium-vivax

• Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity#898898ClinicalTrials.gov
• The Plasmodium vivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes#236936Repositorio institucional EdocUR
• Comparative Study of Thrombocytopenia in Plasmodium Vivax and Falciparum Malaria#835482ClinicalTrials.gov
• Genomic Insights Into Host Shifts Between Plasmodium vivax and Plasmodium simium in Latin America#330111HAL (France)
• Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax#869261ClinicalTrials.gov
• Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax#897723ClinicalTrials.gov
• Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan#914822ClinicalTrials.gov
• Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia#829839ClinicalTrials.gov
• Malaria#342763Repositorio de datos de investigación de la Universidad de Chile Dataverse OAI Archive
• Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria#803877ClinicalTrials.gov
• Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar#876376ClinicalTrials.gov
• Malaria Genetic Surveillance#1009447ClinicalTrials.gov
• Prise en charge des cas de paludisme à Plasmodium vivax : un guide de terrain#296423WHO IRIS
• Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, identity-by-descent and model-based classification#147464HAL (France)
• Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia#366655ClinicalTrials.gov
• Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers#184940ClinicalTrials.gov
• Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults#387198ClinicalTrials.gov
• Plasmodium vivax Transmission in Africa.#20032DOAJ
• PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria#146245ClinicalTrials.gov
• YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates#205757HAL (France)
• Comparable severity of <i>Plasmodium vivax</i> and <i>Plasmodium falciparum</i> malaria in hospitalized patients in the Peruvian Amazon#1038712Europe PMC
• Splenectomised and spleen intact Aotus monkeys'immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.#396873Repositorio institucional EdocUR
• Application of 23 Novel Serological Markers for Identifying Recent Exposure to Plasmodium vivax Parasites in an Endemic Population of Western Thailand#1054563Open Research
• A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes#805385ClinicalTrials.gov
• Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1)#345453Repositório Institucional da Universidade Federal de Sergipe
• Self-assembling functional programmable protein array for studying protein-protein interactions in malaria parasites#236920Repositorio institucional EdocUR
• Pv3Rs: Plasmodium vivax relapse, recrudescence, and reinfection statistical genetic inference#268673HAL (France)
• Serological Markers Predict Plasmodium vivax Relapses in Returning Indonesian Soldier Cohorts#353185bioRxiv / medRxiv
• Easy and fast method for expression and native extraction of Plasmodium vivax Duffy binding protein fragments#236928Repositorio institucional EdocUR
• Application of 23 Novel Serological Markers for Identifying Recent Exposure to <i>Plasmodium vivax</i> Parasites in an Endemic Population of Western Thailand#360956Open Research
• Efficacy of low-dose primaquine plus artemether-lumefantrine or dihydroartemisinin-piperaquine for radical cure of Plasmodium vivax in the Solomon Islands: a randomised clinical trial#147463HAL (France)
• Malaria transmission structure in the Peruvian Amazon through antibody signatures to Plasmodium vivax#308268HAL (France)
• Prevalence of Pfhrp2 and/or Pfhrp3 Gene Deletions in Plasmodium Falciparum Isolates and the Performance of Hrp2 Based Malaria Rapid Diagnostic Tests#486347University of Ghana Digital Collections (UGSpace)
• Accessing invasion-competent Plasmodium vivax merozoites reveals antibody-dependent NK cell activation#4802Europe PMC
• PvGAP: Development of a globally-applicable, highly-multiplexed microhaplotype amplicon panel for Plasmodium vivax#10137bioRxiv / medRxiv
• Data Management and Sharing Plan for: Applying novel tools to parse Plasmodium vivax relapses in clinical trials#216168UNC Dataverse Dataverse OAI Archive
• Plasmodium vivax and Plasmodium falciparum mixed infections in human and mosquito hosts: the impact of multi-species infection on parasite densities and transmission to mosquitoes#18840bioRxiv / medRxiv
• Defining mechanisms of protective antibody responses induced by vaccines against blood-stage Plasmodium vivax malaria#211635Ora Oxford University Research
• Tafenoquine and Primaquine in Colostrum and Breast Milk#911330ClinicalTrials.gov
• Molecular Surveillance of Plasmodium vivax and Plasmodium falciparum Drug Resistance Genes in the Republic of Korea: 2022–2025#231323Europe PMC
• Efficacy of chloroquine in the treatment of <i>Plasmodium vivax</i> malaria in Turkey#384238CiNii
• Genomic characterization and phylogenetic placement of Matryoshka RNA virus 1 associated with Plasmodium vivax malaria in Africa.#975676NCBI PubMed Central
• Different clinical forms of Plasmodium vivax infection result in unique T cell epitope-specific immune responses.#140551NCBI PubMed Central
• Variation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern Ethiopia#304846LSHTM Data Compass
• Genome-wide characterization of Plasmodium vivax infections in local travelers and non-travelers from the Peruvian Amazon.#382511NCBI PubMed Central
• Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivax#154720ClinicalTrials.gov
• Climate change and Plasmodium vivax Malaria Risk in Brazil: Developing adaptive tool for Brazilian Municipalities.#242516NCBI PubMed Central
• Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate–high malaria transmission intensity#308269HAL (France)
• Risk perceptions of high-dose primaquine and tafenoquine among Plasmodium vivax malaria stakeholders in Ethiopia: a qualitative study.#340334NCBI PubMed Central
• Putative Contribution of 8-Aminoquinolines to Preventing Recrudescence of Malaria#410648WIReDSpace